Shopping Cart 0
Cart Subtotal
AED 0

The Broad Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It offers research to assemble molecular components and define the biological circuits that underlie cellular responses. The organization also operates various research projects uncover the molecular basis of major inherited diseases and unearth all the mutations that underlie different cancer types. Broad Institute is headquartered in Cambridge, Massachusetts, the US.

The Broad Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 15

Partnerships 15

DefiniGen Enters into Licensing Agreement with Broad Institute 15

Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16

Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17

Eisai Enters into Research Agreement with Broad Institute 18

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19

Broad Institute Genomic Services Partners with Takeda Pharma 20

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23

Eisai Enters into Research Agreement with Broad Institute 24

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31

Licensing Agreements 32

Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37

Applied Stemcell Enters into licensing Agreement with Broad Institute 39

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40

Evotec Enters into Licensing Agreement with Broad Institute 41

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48

The Broad Institute Inc-Key Competitors 49

The Broad Institute Inc-Key Employees 50

The Broad Institute Inc-Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Recent Developments 52

Strategy And Business Planning 52

Oct 10, 2017: Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare 52

Legal and Regulatory 53

Sep 13, 2018: US Appeals Court upholds ruling on CRISPR patents in favour of Broad Institute 53

Government and Public Interest 55

Sep 10, 2018: Protein analysis uncovers new cancer subtypes for medulloblastoma 55

Aug 15, 2018: New genome analysis scores risk of serious common diseases 57

Jul 24, 2018: Researchers identify immune system mechanism that regulates inflammation 58

Apr 24, 2018: A Leading Method in Human Genetics Studies May Need to Be Reconsidered, as Researchers Discover Significant Distortions 59

Apr 02, 2018: Disease-Causing Mobile Element Identified with SMRT Sequencing, Validated with CRISPR 60

Mar 19, 2018: Metastatic Prostate Cancer Project Explores a New Approach to Genomics Research 61

Dec 20, 2017: CRISPR therapy preserves hearing in progressive deafness model 63

Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 65

Product News 67

May 18, 2017: Cohen Veterans Bioscience and the Broad Institute's Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress Disorder 67

Jan 09, 2018: Broad Institute releases open-source GATK4 software for genome analysis, optimized for speed and scalability 68

Other Significant Developments 70

Aug 13, 2018: Predicting risk for common deadly diseases from millions of genetic variants 70

Jul 10, 2017: Broad Institute of MIT and Harvard Joins Discussions to Create Worldwide CRISPR-Cas9 Licensing Pool 72

May 24, 2017: BGI to work with Broad Institute, Intel and Alibaba Cloud to provide free access to GATK4 on BGI Online 73

Appendix 74

Methodology 74

About GlobalData 74

Contact Us 74

Disclaimer 74


List Of Figure

List of Figures

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

DefiniGen Enters into Licensing Agreement with Broad Institute 15

Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16

Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17

Eisai Enters into Research Agreement with Broad Institute 18

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19

Broad Institute Genomic Services Partners with Takeda Pharma 20

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23

Eisai Enters into Research Agreement with Broad Institute 24

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31

Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37

Applied Stemcell Enters into licensing Agreement with Broad Institute 39

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40

Evotec Enters into Licensing Agreement with Broad Institute 41

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48

The Broad Institute Inc, Key Competitors 49

The Broad Institute Inc, Key Employees 50

The Broad Institute Inc, Other Locations 51

The Broad Institute Inc, Subsidiaries 51

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

The Broad Institute Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It offers research to assemble molecular components and define the biological circuits that underlie cellular responses. The organization also operates various research projects uncover the molecular basis of major inherited diseases and unearth all the mutations that underlie different cancer types. Broad Institute is headquartered in Cambridge, Massachusetts, the US.

The Broad Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 15

Partnerships 15

DefiniGen Enters into Licensing Agreement with Broad Institute 15

Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16

Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17

Eisai Enters into Research Agreement with Broad Institute 18

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19

Broad Institute Genomic Services Partners with Takeda Pharma 20

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23

Eisai Enters into Research Agreement with Broad Institute 24

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31

Licensing Agreements 32

Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37

Applied Stemcell Enters into licensing Agreement with Broad Institute 39

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40

Evotec Enters into Licensing Agreement with Broad Institute 41

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48

The Broad Institute Inc-Key Competitors 49

The Broad Institute Inc-Key Employees 50

The Broad Institute Inc-Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Recent Developments 52

Strategy And Business Planning 52

Oct 10, 2017: Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare 52

Legal and Regulatory 53

Sep 13, 2018: US Appeals Court upholds ruling on CRISPR patents in favour of Broad Institute 53

Government and Public Interest 55

Sep 10, 2018: Protein analysis uncovers new cancer subtypes for medulloblastoma 55

Aug 15, 2018: New genome analysis scores risk of serious common diseases 57

Jul 24, 2018: Researchers identify immune system mechanism that regulates inflammation 58

Apr 24, 2018: A Leading Method in Human Genetics Studies May Need to Be Reconsidered, as Researchers Discover Significant Distortions 59

Apr 02, 2018: Disease-Causing Mobile Element Identified with SMRT Sequencing, Validated with CRISPR 60

Mar 19, 2018: Metastatic Prostate Cancer Project Explores a New Approach to Genomics Research 61

Dec 20, 2017: CRISPR therapy preserves hearing in progressive deafness model 63

Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 65

Product News 67

May 18, 2017: Cohen Veterans Bioscience and the Broad Institute's Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress Disorder 67

Jan 09, 2018: Broad Institute releases open-source GATK4 software for genome analysis, optimized for speed and scalability 68

Other Significant Developments 70

Aug 13, 2018: Predicting risk for common deadly diseases from millions of genetic variants 70

Jul 10, 2017: Broad Institute of MIT and Harvard Joins Discussions to Create Worldwide CRISPR-Cas9 Licensing Pool 72

May 24, 2017: BGI to work with Broad Institute, Intel and Alibaba Cloud to provide free access to GATK4 on BGI Online 73

Appendix 74

Methodology 74

About GlobalData 74

Contact Us 74

Disclaimer 74


List Of Figure

List of Figures

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

The Broad Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 10

The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

DefiniGen Enters into Licensing Agreement with Broad Institute 15

Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16

Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17

Eisai Enters into Research Agreement with Broad Institute 18

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19

Broad Institute Genomic Services Partners with Takeda Pharma 20

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23

Eisai Enters into Research Agreement with Broad Institute 24

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31

Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35

Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37

Applied Stemcell Enters into licensing Agreement with Broad Institute 39

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40

Evotec Enters into Licensing Agreement with Broad Institute 41

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48

The Broad Institute Inc, Key Competitors 49

The Broad Institute Inc, Key Employees 50

The Broad Institute Inc, Other Locations 51

The Broad Institute Inc, Subsidiaries 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

The Broad Institute Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.